𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of diclofenac in rat model of diabetes mellitus induced by alloxan or steptozotocin

✍ Scribed by Yu C. Kim; Eun Y. Oh; So H. Kim; Myung G. Lee

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
109 KB
Volume
27
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pharmacokinetics and pharmacodynamics of
Pharmacokinetics and pharmacodynamics of intravenous torasemide in diabetic rats induced by alloxan or streptozotocin
✍ Yu C. Kim; Eun Y. Oh; So H. Kim; Myung G. Lee πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 107 KB πŸ‘ 1 views

The pharmacokinetic and pharmacodynamic parameters of torasemide were compared after intravenous administration at a dose of 2 mg/kg to diabetic rats induced by alloxan (DMIA) or streptozotocin (DMIS), and their respective control rats. It was reported that torasemide was mainly metabolized via CYP2

Pharmacokinetics of 5-fluorouracil in ra
Pharmacokinetics of 5-fluorouracil in rats with diabetes mellitus induced by streptozotocin
✍ Young H. Choi; Ae K. Lee; Soo K. Bae; Sun O. Kim; Myung G. Lee πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 2 views

## Abstract The pharmacokinetic parameters of 5‐fluorouracil were compared after intravenous administration at a dose of 30 mg/kg to control Sprague–Dawley rats and to rats with diabetes mellitus induced by streptozotocin (DMIS). In DMIS rats, the area under the plasma concentration–time curve from

Pharmacokinetics of a new carbapenem, DA
Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with alloxan-induced diabetes mellitus
✍ So H. Kim; Won B. Kim; Myung G. Lee πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 153 KB πŸ‘ 1 views

Because physiological changes occurring in diabetes patients could alter the pharmacokinetics of drugs used to treat the disease, the pharmacokinetics and tissue distribution of DA-1131, a new carbapenem antibiotic, were investigated after 1-min intravenous (iv) administration of the drug, 50 mg kg

Pharmacokinetic and pharmacodynamic chan
Pharmacokinetic and pharmacodynamic changes of furosemide after intravenous and oral administration to rats with alloxan-induced diabetes mellitus
✍ Joo H. Park; Woo I. Lee; Woo H. Yoon; Young-D. Park; Jung-S. Lee; Myung G. Lee πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 163 KB πŸ‘ 2 views

Because some physiological changes occurring in diabetes mellitus patients could alter the pharmacokinetics and pharmacodynamics of the drugs to treat the disease, the pharmacokinetics and pharmacodynamics of furosemide were investigated after intravenous (i.v.) and oral administration of the drug (

Pharmacokinetic changes of diltiazem and
Pharmacokinetic changes of diltiazem and desacetyldiltiazem after oral administration of diltiazem in rabbits with diabetes mellitus induced by alloxan
✍ Jun S. Choi; Yoon G. Kim πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 142 KB πŸ‘ 2 views

## Abstract Physiological changes occurring in diabetes mellitus patients could alter the pharmacokinetics of drugs used to treat hypertension resulting from diabetic complications. Hence, the pharmacokinetics of diltiazem (DTZ) and its metabolite, desacetyldiltiazem (DAD), were investigated after